Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections

Curr Opin Immunol. 2021 Oct:72:126-134. doi: 10.1016/j.coi.2021.04.005. Epub 2021 May 15.

Abstract

Membrane cofactor protein (MCP; CD46), a ubiquitously expressed complement regulatory protein, serves as a cofactor for serine protease factor I to cleave and inactivate C3b and C4b deposited on host cells. However, CD46 also plays roles in human reproduction, autophagy, modulating T cell activation and effector functions and is a member of the newly identified intracellular complement system (complosome). CD46 also is a receptor for 11 pathogens ('pathogen magnet'). While CD46 deficiencies contribute to inflammatory disorders, its overexpression in cancers and role as a receptor for some adenoviruses has led to its targeting by oncolytic agents and adenoviral-based therapeutic vectors, including coronavirus disease of 2019 (COVID-19) vaccines. This review focuses on recent advances in identifying disease-causing CD46 variants and its pathogen connections.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Autophagy
  • COVID-19 / immunology*
  • COVID-19 Vaccines / immunology*
  • Complement Activation
  • Host-Pathogen Interactions
  • Humans
  • Lymphocyte Activation
  • Membrane Cofactor Protein / genetics
  • Membrane Cofactor Protein / metabolism*
  • Oncolytic Virotherapy
  • Polymorphism, Genetic
  • Reproduction
  • SARS-CoV-2 / physiology*
  • T-Lymphocytes / immunology*

Substances

  • COVID-19 Vaccines
  • Membrane Cofactor Protein
  • Ad5-nCoV vaccine